Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Chencheng Xie, Dina Halegoua‐DeMarzio
Nutrients (2019) Vol. 11, Iss. 11, pp. 2837-2837
Open Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

Selegiline ameliorated dyslipidemia and hepatic steatosis in high-fat diet mice
Zhen Tian, Xinyue Wang, Tianshu Han, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109901-109901
Closed Access | Times Cited: 11
Gut microbial response to host metabolic phenotypes
Jinliang Hou, Jianguo Xiang, Deliang Li, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 14
The Role of the Stress Response in Metabolic Dysfunction-Associated Fatty Liver Disease: A Psychoneuroendocrineimmunology-Based Perspective
Ilaria Demori, Elena Grasselli
Nutrients (2023) Vol. 15, Iss. 3, pp. 795-795
Open Access | Times Cited: 8
Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice
Danni Qu, Mengyun Chen, Haiyan Zhu, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 684, pp. 149131-149131
Closed Access | Times Cited: 8
The role of the gut microbiome in the development of hepatobiliary cancers
Neil Daniel, Flavia Genua, Mazda Jenab, et al.
Hepatology (2023) Vol. 80, Iss. 5, pp. 1252-1269
Open Access | Times Cited: 7
Fructooligosaccharides and galactooligosaccharides improve hepatic steatosis via gut microbiota-brain axis modulation
Rodrigo Soares da Silva, Ingrid Prata Mendonça, Igor Henrique Rodrigues de Paiva, et al.
International Journal of Food Sciences and Nutrition (2023) Vol. 74, Iss. 7, pp. 760-780
Closed Access | Times Cited: 7
Reduced liver damage and fibrosis with combined SCD Probiotics and intermittent fasting in aged rat
Hikmet Taner Teker, Taha Ceylani, Seda Keskin, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Molecular mechanisms of hepatic lipid metabolism disorders: Focus on mitochondrial quality control
Jiachi Yu, Jia Huang, Tian Xia, et al.
Portal hypertension & cirrhosis (2024)
Open Access | Times Cited: 2
The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis
Yuxue Wang, Yarong Wang, Jianguang Sun
Bioengineered (2022) Vol. 13, Iss. 7-12, pp. 14960-14973
Open Access | Times Cited: 8
Metabolic characterization of selected probiotic consortia during gluten and wheat bread simulated digestion
Mirco Vacca, Giuseppe Celano, Olga Nikoloudaki, et al.
Deleted Journal (2024)
Open Access | Times Cited: 1
Nonalcoholic fatty liver disease associated with obesity and type 2 diabetes and gut dysbiosis
T. М. Bentsa
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2024) Vol. 20, Iss. 2, pp. 120-125
Open Access | Times Cited: 1
Primary Prevention Strategy for Non-Communicable Diseases (NCDs) and Their Risk Factors: The Role of Intestinal Microbiota
Itzel Ivonn López-Tenorio, Óscar Rodrigo Aguilar-Villegas, Yoshua Espinoza-Palacios, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2529-2529
Open Access | Times Cited: 1
Combination of Limosilactobacillus fermentum MG4231 and MG4244 attenuates lipid accumulation in high-fat diet-fed obese mice
Suk-Jin Kim, Soo‐Im Choi, Miran Jang, et al.
Beneficial Microbes (2021) Vol. 12, Iss. 5, pp. 479-492
Open Access | Times Cited: 9
Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
Wensheng Che, Ming Zhao, Xiaoqing Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 5
Crosstalk between Gut Microbiota and Hepatocellular Carcinoma
Chencheng Xie, Christine Pocha
Gastrointestinal Disorders (2023) Vol. 5, Iss. 2, pp. 127-143
Open Access | Times Cited: 2
Role of Probiotics and Gut microbiota in Liver Diseases
Safeena Beevi S S, Biju Pottakkat, S. Narayanan
Asian Journal of Nursing Education and Research (2023), pp. 157-161
Closed Access | Times Cited: 2
Os efeitos do uso de antibióticos na microbiota intestinal
Izabelly Souza da Cunha, José Moreira da Silva, Natasha Soares, et al.
Research Society and Development (2023) Vol. 12, Iss. 12, pp. e125121244044-e125121244044
Open Access | Times Cited: 2
Lactobacillus johnsonii BS15 combined with abdominal massage on intestinal permeability in rats with nonalcoholic fatty liver and cell biofilm repair
Wei Zhang, Huanan Li, Na Zhao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6354-6363
Open Access | Times Cited: 5
Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation
Kinga Czarnecka, Paulina Czarnecka, Olga Tronina, et al.
Immunity Inflammation and Disease (2021) Vol. 10, Iss. 1, pp. 3-21
Open Access | Times Cited: 5
Synbiotic Supplementation Modulates Gut Microbiota, Regulates β-Catenin Expression and Prevents Weight Gain in ob/ob Mice: Preliminary Findings
Sebastião Mauro Bezerra Duarte, José Tadeu Stefano, Lucas Augusto Moysés Franco, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10483-10483
Open Access | Times Cited: 3
Probiotics as a Sustainable Approach in Health Enrichment
Ashwin Rajeev, Aiswarya Sudheer, Indranil Chattopadhyay
Journal of Pure and Applied Microbiology (2024) Vol. 18, Iss. 1, pp. 80-99
Open Access
Suppression of P2X4 and P2X7 by Lactobacillus rhamnosus vitaP1: effects on hangover symptoms
Jeong Eun Kwon, Woojae Hong, Hyelin Jeon, et al.
AMB Express (2024) Vol. 14, Iss. 1
Open Access
Probiotics—A Promising Novel Therapeutic Approach in the Management of Chronic Liver Diseases
Gokulapriya Ramachandran, Biju Pottakkat
Journal of Medicinal Food (2024) Vol. 27, Iss. 6, pp. 467-476
Closed Access
Cardiometabolic Risk in Non-Diabetic MAFLD Patients: Insights from the Triglyceride–Glucose, Plasma Atherogenic, and Cardiometabolic Index
Sedat Çiftel, Serpil Çiftel, Ahmed Ramiz Baykan, et al.
Archives of Medical Science (2024)
Open Access
INTESTINAL MICROBIOTA AND LIVER AND KIDNEY DISEASES
Владимир Александрович Карпин, Ольга Ивановна Шувалова
(2024), pp. 39-42
Closed Access

Scroll to top